Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers

por Kilvaer, Thomas K., Khanehkenari, Mehrdad Rakaee, Hellevik, Turid, Al-Saad, Samer, Paulsen, Erna-Elise, Bremnes, Roy M., Busund, Lill-Tove, Donnem, Tom, Martinez, Inigo Z.
Publicado 2015

The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort

por Ness, Nora, Andersen, Sigve, Khanehkenari, Mehrdad Rakaee, Nordbakken, Cecilie V., Valkov, Andrej, Paulsen, Erna-Elise, Nordby, Yngve, Bremnes, Roy M., Donnem, Tom, Busund, Lill-Tove, Richardsen, Elin
Publicado 2017

Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome

por Grindstad, Thea, Skjefstad, Kaja, Andersen, Sigve, Ness, Nora, Nordby, Yngve, Al-Saad, Samer, Fismen, Silje, Donnem, Tom, Khanehkenari, Mehrdad Rakaee, Busund, Lill-Tove, Bremnes, Roy M., Richardsen, Elin
Publicado 2016

CD45RO(+) Memory T Lymphocytes — a Candidate Marker for TNM-Immunoscore in Squamous Non–Small Cell Lung Cancer()

por Paulsen, Erna-Elise, Kilvaer, Thomas, Khanehkenari, Mehrdad Rakaee, Maurseth, Ramona Johansen, Al-Saad, Samer, Hald, Sigurd M., Al-Shibli, Khalid, Andersen, Sigve, Richardsen, Elin, Busund, Lill-Tove, Bremnes, Roy, Donnem, Tom
Publicado 2015